| 2-DG | 2-deoxy-D-glucose |
| 3-BrPA | 3-bromopyruvate |
| 3-IAA | indole-3-acetic acid |
| 18F-FDG | fluorine-18 fluorodeoxyglucose |
| 53BP1 | p53-binding protein 1 |
| AARS2 | alanyl-tRNA synthetase 2 |
| ACAT1 | acetyl-CoA acetyltransferase 1 |
| ACC | acetyl-CoA carboxylase |
| ACLY | ATP citrate lyase |
| ACSL5 | acyl-CoA synthetase long-chain family member 5 |
| ACSS2 | acyl-CoA synthetase short-chain family member 2 |
| ADI-PEG20 | pegylated arginine deiminase |
| AhR | aryl hydrocarbon receptor |
| AKT | protein kinase B |
| α-KG | α-ketoglutarate |
| α-SMA | α-smooth muscle actin |
| ALYREF | Aly/REF export factor |
| AMP | adenosine monophosphate |
| AMPK | AMP-activated protein kinase |
| APC | adenomatous polyposis coli |
| ASNS | asparagine synthetase |
| ASS1 | argininosuccinate synthase 1 |
| ATP | adenosine triphosphate |
| AUC | area under the curve |
| AXIN | axis inhibition protein |
| BBN | N-butyl-N-(4-hydroxybutyl) nitrosamine |
| BC | bladder cancer |
| BCG | bacillus Calmette-Guerin |
| β-TrCP | β-transducin repeat-containing protein |
| BNIP3 | BCL2 interacting protein 3 |
| CAB39 | calcium-binding protein 39 |
| CAF | cancer-associated fibroblast |
| cAMP | cyclic adenosine monophosphate |
| CBL | Cbl proto-oncogene |
| CD147 | cluster of differentiation 147 |
| CD36 | cluster of differentiation 36 |
| CD39 | cluster of differentiation 39 |
| CD73 | cluster of differentiation 73 |
| CD8 | cluster of differentiation 8 |
| CDCA3 | cell division cycle-associated protein 3 |
| CDKN1A | cyclin-dependent kinase inhibitor 1A |
| CDKN3 | cyclin-dependent kinase inhibitor 3 |
| CDX | cell-derived xenograft |
| CI | confidence interval |
| circRNA | circular RNA |
| CK1 | casein kinase 1 |
| COL1A1 | collagen type I alpha 1 chain |
| COMPASS | complex of proteins associated with Set1 |
| CPT1A | carnitine palmitoyltransferase 1A |
| CRISPR | clustered regularly interspaced short palindromic repeats |
| CT | computed tomography |
| CTGF | connective tissue growth factor |
| CTLA-4 | cytotoxic T-lymphocyte-associated protein 4 |
| CUL4B/RBX1 | cullin 4B/RING-box protein 1 |
| CUT&Tag | cleavage under targets and tagmentation |
| CXCL12 | C-X-C motif chemokine ligand 12 |
| CYLD | cylindromatosis |
| DeltaSUVmean | change in mean standardised uptake value |
| DHCR7 | 7-dehydrocholesterol reductase |
| DLGAP5 | discs large-associated protein 5 |
| DNA | deoxyribonucleic acid |
| DNMT1 | DNA methyltransferase 1 |
| E2F | E2F transcription factor family |
| ENO1 | enolase 1 |
| EP300 | E1A-binding protein p300 |
| ER | endoplasmic reticulum |
| FAK | focal adhesion kinase |
| FAPI | fibroblast-activation-protein inhibitor |
| FASN | fatty acid synthase |
| FBXW7 | F-box and WD repeat domain-containing 7 |
| FGFR3 | fibroblast growth factor receptor 3 |
| FOXP3 | forkhead box P3 |
| G3BP1 | Ras GTPase-activating protein-binding protein 1 |
| GABPA | GA-binding protein transcription factor subunit alpha |
| GADD45B | growth arrest and DNA damage-inducible beta |
| GC–MS | gas chromatography–mass spectrometry |
| GCN2 | general control non-derepressible 2 |
| GLOBOCAN | Global Cancer Observatory |
| GLS | glutaminase |
| GLS1 | glutaminase 1 |
| GLUD | glutamate dehydrogenase |
| GLUT1 | glucose transporter 1 |
| GPT2 | glutamic-pyruvic transaminase 2 |
| GPX4 | glutathione peroxidase 4 |
| GSDMD | gasdermin D |
| GSH | glutathione |
| GSK3β | glycogen synthase kinase 3 beta |
| H3K18la | histone H3 lysine 18 lactylation |
| H3K27me3 | histone H3 lysine 27 trimethylation |
| H3K9la | histone H3 lysine 9 lactylation |
| H4K5la | histone H4 lysine 5 lactylation |
| HIF-1α | hypoxia-inducible factor 1 alpha |
| HILIC | hydrophilic interaction liquid chromatography |
| HK1 | hexokinase 1 |
| HK2 | hexokinase 2 |
| hnRNP I/L | heterogeneous nuclear ribonucleoproteins I/L |
| HR | hazard ratio |
| HRMS | high-resolution mass spectrometry |
| HSF1 | heat shock factor 1 |
| HSL | hormone-sensitive lipase |
| HSP90β | heat shock protein 90 beta family member 1 |
| ICI | immune-checkpoint inhibitor |
| IDH | isocitrate dehydrogenase |
| IDO1 | indoleamine 2,3-dioxygenase 1 |
| IFN-γ | interferon gamma |
| IGF2BP | insulin-like growth factor 2 mRNA-binding protein |
| IL | interleukin |
| IRF3 | interferon regulatory factor 3 |
| JAK2 | Janus kinase 2 |
| JmjC | Jumonji C domain |
| JMJD1A | Jumonji domain-containing 1A |
| KDM6A | lysine demethylase 6A |
| KDM6B | lysine demethylase 6B |
| LAG-3 | lymphocyte-activation gene 3 |
| LC–MS/MS | liquid chromatography–tandem mass spectrometry |
| LC3 | microtubule-associated protein 1 light chain 3 |
| LCN2 | lipocalin 2 |
| LDH | lactate dehydrogenase |
| LDHA | lactate dehydrogenase A |
| LDI-MS | laser desorption/ionisation mass spectrometry |
| LDL | low-density lipoprotein |
| LIPT1 | lipoyltransferase 1 |
| LKB1 | liver kinase B1 |
| lncRNA | long non-coding RNA |
| LRP5/6 | low-density lipoprotein receptor-related protein 5/6 |
| LRP8 | low-density lipoprotein receptor-related protein 8 |
| m5C | 5-methylcytosine |
| m6A | N6-methyladenosine |
| MAPK | mitogen-activated protein kinase |
| MAVS | mitochondrial antiviral-signalling protein |
| MAX | MYC-associated factor X |
| MCT1 | monocarboxylate transporter 1 |
| MCT4 | monocarboxylate transporter 4 |
| MGAT4A | mannosyl-glycoprotein N-acetylglucosaminyltransferase 4A |
| MHC-I | major histocompatibility complex class I |
| MIBC | muscle-invasive bladder cancer |
| miR-30e | microRNA-30e |
| MLL3/4 | mixed-lineage leukaemia proteins 3 and 4 |
| mRNA | messenger RNA |
| MTCO1 | mitochondrially encoded cytochrome c oxidase I |
| mTOR | mammalian/mechanistic target of rapamycin |
| mTORC1 | mechanistic target of rapamycin complex 1 |
| MYC | MYC proto-oncogene, basic helix-loop-helix transcription factor |
| NAD+ | oxidised nicotinamide adenine dinucleotide |
| NADPH | nicotinamide adenine dinucleotide phosphate |
| NDUFB8 | NADH:ubiquinone oxidoreductase subunit B8 |
| NF-κB | nuclear factor kappa B |
| NFAT1 | nuclear factor of activated T cells 1 |
| NK | natural killer |
| NLRP1 | NLR family pyrin domain-containing 1 |
| NMIBC | non-muscle-invasive bladder cancer |
| NMR | nuclear magnetic resonance |
| NOP2 | nucleolar protein 2 |
| ox-LDL | oxidised low-density lipoprotein |
| OXPHOS | oxidative phosphorylation |
| P4HA2 | prolyl 4-hydroxylase subunit alpha 2 |
| P5C | pyrroline-5-carboxylate |
| PD-1 | programmed cell death protein 1 |
| PD-L1 | programmed death-ligand 1 |
| PDH | pyruvate dehydrogenase |
| PDK | pyruvate dehydrogenase kinase |
| PDX | patient-derived xenograft |
| PET/CT | positron-emission tomography/computed tomography |
| PET/MRI | positron-emission tomography/magnetic-resonance imaging |
| PFK | phosphofructokinase |
| PFK1 | phosphofructokinase 1 |
| PGK1 | phosphoglycerate kinase 1 |
| PGM | phosphoglucomutase |
| PGM3 | phosphoglucomutase 3 |
| PHD2 | prolyl hydroxylase domain-containing protein 2 |
| PHGDH | phosphoglycerate dehydrogenase |
| PI3K | phosphoinositide 3-kinase |
| PIK3CA | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
| PKA | protein kinase A |
| PKM2 | pyruvate kinase M2 |
| PPARα | peroxisome proliferator-activated receptor alpha |
| PPARγ | peroxisome proliferator-activated receptor gamma |
| PPP | pentose phosphate pathway |
| PRKN | parkin RBR E3 ubiquitin protein ligase |
| PSMD11 | proteasome 26S subunit, non-ATPase 11 |
| PTEN | phosphatase and tensin homologue |
| PTHrP | parathyroid hormone-related protein |
| PYCR1 | pyrroline-5-carboxylate reductase 1 |
| RB1 | RB transcriptional corepressor 1 |
| RCC | renal cell carcinoma |
| RIG-I | retinoic acid-inducible gene I |
| RNA | ribonucleic acid |
| RNA-seq | RNA sequencing |
| ROC | receiver operating characteristic |
| ROS | reactive oxygen species |
| RUNX2 | runt-related transcription factor 2 |
| S6K1 | ribosomal protein S6 kinase beta-1 |
| SAM | S-adenosylmethionine |
| SCD1 | stearoyl-CoA desaturase 1 |
| SCO2 | synthesis of cytochrome c oxidase 2 |
| SENP3 | SUMO-specific peptidase 3 |
| SLC | solute carrier |
| SLC16A1-AS1 | SLC16A1 antisense RNA 1 |
| SOAT1 | sterol O-acyltransferase 1 |
| SRC | SRC proto-oncogene, non-receptor tyrosine kinase |
| SRC-3 | steroid receptor coactivator 3 |
| SREBP1 | sterol regulatory element-binding protein 1 |
| SRSF1 | serine and arginine rich splicing factor 1 |
| STAT3 | signal transducer and activator of transcription 3 |
| STING | stimulator of interferon genes |
| TACO1 | translational activator of cytochrome c oxidase I |
| TAM | tumour-associated macrophage |
| TCA | tricarboxylic acid |
| TCF/LEF | T-cell factor/lymphoid enhancer-binding factor |
| TDO | tryptophan 2,3-dioxygenase |
| TET | ten-eleven translocation dioxygenase |
| TGF-β | transforming growth factor beta |
| TIGAR | TP53-induced glycolysis and apoptosis regulator |
| TIM-3 | T-cell immunoglobulin and mucin domain-containing protein 3 |
| TME | tumour microenvironment |
| TP53 | tumour protein p53 |
| Treg | regulatory T cell |
| TRIM28 | tripartite motif-containing 28 |
| UCA1 | urothelial cancer associated 1 |
| UHPLC–UHRMS | ultra-high-performance liquid chromatography–ultra-high-resolution mass spectrometry |
| UPLC–MS | ultra-performance liquid chromatography–mass spectrometry |
| USP43 | ubiquitin-specific peptidase 43 |
| VDAC1 | voltage-dependent anion channel 1 |
| XBP1 | X-box-binding protein 1 |
| YAP | Yes-associated protein |
| YBX1 | Y-box binding protein 1 |
| YME1L1 | YME1-like 1 ATPase |
| YTHDC1 | YTH domain-containing protein 1 |
| YTHDF2 | YTH N6-methyladenosine RNA binding protein 2 |
| YTHDF3 | YTH N6-methyladenosine RNA binding protein 3 |
| YY1 | Yin Yang 1 |